Morgan Keegan Starts Coverage on 10 Healthcare Stocks: ABT, BSX, STJ at Outperform, JNJ, MDT at Market Perform

Article Stock Quotes (10) Comments (0)

In the Healthcare group Friday morning, Morgan Keegan's Jan Wald initiated coverage on the following stocks:

• Abbott Labs (NYSE: ABT) with an Outperform rating and a $61 price target
  
• Boston Scientific (NYSE: BSX) with an Outperform rating and a $8 price target
  
• St. Jude (NYSE: STJ) with an Outperform rating and a $60 price target
  
• DexCom (Nasdaq: DXCM) with an Outperform rating and a $18 price target
  
• HeartWare (Nasdaq: HTWR) with an Outperform rating and a $87 price target
  
• J&J (NYSE: JNJ) with a Market Perform rating and a $70 price target
  
• Medtronic (NYSE: MDT) with a Market Perform rating and a $43 price target
  
• Edwards Lifesciences (NYSE: EW) with a Market Perform rating and a $97 price target
  
• Thoratec (Nasdaq: THOR) with a Market Perform rating and a $35 price target
  
• AtriCure (Nasdaq: ATRC) with a Market Perform rating and a $14 price target

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
• Jefferies Starts BioScrip (BIOS) at Buy, $17 PT
• UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind

Create E-mail Alert Related Categories

New Coverage

Related Entities

Morgan Keegan & Company

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?